CGEN Earnings & Financial Statements
Compugen Ltd.
$2.00
+$0.02(+1.01%)
48
Overall
80
Value
18
Tech
47
Quality
Market Cap
$189.17M
Volume
378.10K
52W Range
$1.43 - $3.24
Target Price
$4.60
CGEN earnings and financial statements: Compugen Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CGEN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $72.76M | $27.86M | $33.46M | $7.50M | $6.00M |
| Cost of revenue | $9.25M | $7.93M | $2.00M | -$975.0K | $680.0K |
| Operating income | $31.33M | -$14.89M | -$12.99M | -$35.37M | -$35.07M |
| EBITDA | $35.39M | -$10.80M | -$9.59M | -$33.74M | -$33.27M |
| Net income | $35.34M | -$14.23M | -$18.75M | -$33.69M | -$34.20M |
| EPS (diluted) | $0.38 | $-0.16 | $-0.21 | $-0.39 | $-0.41 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $156.57M | $115.00M | $121.33M | $94.18M | $132.16M |
| Total liabilities | $53.84M | $60.08M | $55.77M | $16.50M | $25.47M |
| Shareholders’ equity | $102.73M | $54.91M | $65.56M | $77.68M | $106.69M |
| Cash and equivalents | $136.36M | $79.63M | $38.94M | $11.42M | $8.51M |
| Long-term debt | $2.44M | $2.46M | $719.0K | $1.31M | $1.98M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $31.63M | $49.60M | -$35.89M | -$34.51M | -$22.75M |
| Capital expenditure | - | - | - | -$487.0K | -$289.0K |
| Free cash flow | $31.33M | $49.49M | -$36.06M | -$34.99M | -$22.75M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEN | $2.00 | +1.0% | 378.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |